Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells

  1. Paula Freire-Pritchett
  2. Stefan Schoenfelder
  3. Csilla Várnai
  4. Steven W Wingett
  5. Jonathan Cairns
  6. Amanda J Collier
  7. Raquel García-Vílchez
  8. Mayra Furlan-Magaril
  9. Cameron S Osborne
  10. Peter J Fraser
  11. Peter J Rugg-Gunn  Is a corresponding author
  12. Mikhail Spivakov  Is a corresponding author
  1. The Babraham Institute, United Kingdom
  2. Universidad Nacional Autónoma de México, Mexico
  3. King's College London School of Medicine, United Kingdom

Abstract

Long-range cis-regulatory elements such as enhancers coordinate cell-specific transcriptional programmes by engaging in DNA looping interactions with target promoters. Deciphering the interplay between the promoter connectivity and activity of cis-regulatory elements during lineage commitment is crucial for understanding developmental transcriptional control. Here, we use Promoter Capture Hi-C to generate a high-resolution atlas of chromosomal interactions involving ~22,000 gene promoters in human pluripotent and lineage-committed cells, identifying putative target genes for known and predicted enhancer elements. We reveal extensive dynamics of cis-regulatory contacts upon lineage commitment, including the acquisition and loss of promoter interactions. This spatial rewiring occurs preferentially with predicted changes in the activity of cis-regulatory elements, and is associated with changes in target gene expression. Our results provide a global and integrated view of promoter interactome dynamics during lineage commitment of human pluripotent cells.

Data availability

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Paula Freire-Pritchett

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Stefan Schoenfelder

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Csilla Várnai

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Steven W Wingett

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Jonathan Cairns

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Amanda J Collier

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Raquel García-Vílchez

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Mayra Furlan-Magaril

    Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico
    Competing interests
    The authors declare that no competing interests exist.
  9. Cameron S Osborne

    Department of Genetics and Molecular Medicine, King's College London School of Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Peter J Fraser

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Peter J Rugg-Gunn

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    For correspondence
    peter.rugg-gunn@babraham.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  12. Mikhail Spivakov

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    For correspondence
    mikhail.spivakov@babraham.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0383-3943

Funding

Wellcome (WT093736)

  • Peter J Rugg-Gunn

Biotechnology and Biological Sciences Research Council (BB/J004480/1)

  • Paula Freire-Pritchett
  • Stefan Schoenfelder
  • Csilla Várnai
  • Steven W Wingett
  • Jonathan Cairns
  • Mayra Furlan-Magaril
  • Peter J Fraser
  • Mikhail Spivakov

Medical Research Council (MR/J003808/1)

  • Amanda J Collier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Freire-Pritchett et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,376
    views
  • 1,467
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Paula Freire-Pritchett
  2. Stefan Schoenfelder
  3. Csilla Várnai
  4. Steven W Wingett
  5. Jonathan Cairns
  6. Amanda J Collier
  7. Raquel García-Vílchez
  8. Mayra Furlan-Magaril
  9. Cameron S Osborne
  10. Peter J Fraser
  11. Peter J Rugg-Gunn
  12. Mikhail Spivakov
(2017)
Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells
eLife 6:e21926.
https://doi.org/10.7554/eLife.21926

Share this article

https://doi.org/10.7554/eLife.21926

Further reading

    1. Stem Cells and Regenerative Medicine
    Sujeethkumar Prithiviraj, Alejandro Garcia Garcia ... Paul E Bourgine
    Research Article

    Tissue engineering strategies predominantly rely on the production of living substitutes, whereby implanted cells actively participate in the regenerative process. Beyond cost and delayed graft availability, the patient-specific performance of engineered tissues poses serious concerns on their clinical translation ability. A more exciting paradigm consists in exploiting cell-laid, engineered extracellular matrices (eECMs), which can be used as off-the-shelf materials. Here, the regenerative capacity solely relies on the preservation of the eECM structure and embedded signals to instruct an endogenous repair. We recently described the possibility to exploit custom human stem cell lines for eECM manufacturing. In addition to the conferred standardization, the availability of such cell lines opened avenues for the design of tailored eECMs by applying dedicated genetic tools. In this study, we demonstrated the exploitation of CRISPR/Cas9 as a high precision system for editing the composition and function of eECMs. Human mesenchymal stromal/stem cell (hMSC) lines were modified to knock out vascular endothelial growth factor (VEGF) and Runt-related transcription factor 2 (RUNX2) and assessed for their capacity to generate osteoinductive cartilage matrices. We report the successful editing of hMSCs, subsequently leading to targeted VEGF and RUNX2-knockout cartilage eECMs. Despite the absence of VEGF, eECMs retained full capacity to instruct ectopic endochondral ossification. Conversely, RUNX2-edited eECMs exhibited impaired hypertrophy, reduced ectopic ossification, and superior cartilage repair in a rat osteochondral defect. In summary, our approach can be harnessed to identify the necessary eECM factors driving endogenous repair. Our work paves the road toward the compositional eECMs editing and their exploitation in broad regenerative contexts.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Joshua G Medina-Feliciano, Griselle Valentín-Tirado ... José E Garcia-Arraras
    Research Article

    In holothurians, the regenerative process following evisceration involves the development of a ‘rudiment’ or ‘anlage’ at the injured end of the mesentery. This regenerating anlage plays a pivotal role in the formation of a new intestine. Despite its significance, our understanding of the molecular characteristics inherent to the constituent cells of this structure has remained limited. To address this gap, we employed state-of-the-art scRNA-seq and hybridization chain reaction fluorescent in situ hybridization analyses to discern the distinct cellular populations associated with the regeneration anlage. Through this approach, we successfully identified 13 distinct cell clusters. Among these, two clusters exhibit characteristics consistent with putative mesenchymal cells, while another four show features akin to coelomocyte cell populations. The remaining seven cell clusters collectively form a large group encompassing the coelomic epithelium of the regenerating anlage and mesentery. Within this large group of clusters, we recognized previously documented cell populations such as muscle precursors, neuroepithelial cells, and actively proliferating cells. Strikingly, our analysis provides data for identifying at least four other cellular populations that we define as the precursor cells of the growing anlage. Consequently, our findings strengthen the hypothesis that the coelomic epithelium of the anlage is a pluripotent tissue that gives rise to diverse cell types of the regenerating intestinal organ. Moreover, our results provide the initial view into the transcriptomic analysis of cell populations responsible for the amazing regenerative capabilities of echinoderms.